Navigation Links
'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss
Date:7/1/2008

Findings in rats show promise for 'buying time' in victims of lethal

hemorrhage

SEATTLE, July 1 /PRNewswire/ -- For the first time, researchers have demonstrated that the administration of minute amounts of inhaled or intravenous hydrogen sulfide, or H2S -- the molecule that gives rotten eggs their sulfurous stench -- significantly improves survival from extreme blood loss in rats.

Cell biologist Mark B. Roth, Ph.D., and colleagues in the Basic Sciences Division of Fred Hutchinson Cancer Research Center, in collaboration with surgeon Robert K. Winn, Ph.D., and colleagues at UW Medicine's Harborview Medical Center, report their findings online ahead of print in The Journal of Trauma Injury, Infection, and Critical Care. The article is slated for the July print issue, which comes out on July 10.

The researchers successfully used H2S to induce a state of reversible metabolic hibernation as a way to reduce death from insufficient blood supply to organs and tissues in a rat model of lethal hemorrhage. (Federal regulations mandate the use of such animal models in preclinical research to test the safety and effectiveness of various procedures and treatments before they can be tested in humans.)

They found that 75 percent of rats (18 of 24) given inhaled hydrogen sulfide and 67 percent of rats (eight of 12) given intravenous hydrogen sulfide survived at least two weeks -- the duration of the monitoring period -- after losing more than half of their blood for an extended period. In contrast, long-term survival rates for the untreated rats in the two control groups were 23 percent (three of 13) and 14 percent (one of seven), respectively.

"Our goal is to develop life-saving treatment for critically ill people suffering from acute, sustained blood loss, such as in a car accident or on the battlefield," said senior author Roth. "These findings have obvious implications for the military, but they also h
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection
2. Phase III Data Show Vanda Pharmaceuticals Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia
3. New Study: Pine Bark Significantly Reduces Menstrual Pain
4. Novel Testosterone Gel Significantly Improves Insulin Sensitivity and Sexual Function in Hypogonadal Men With Type 2 Diabetes and Metabolic Syndrome
5. ACTEMRA(R) (tocilizumab) Significantly Reduces Rheumatoid Arthritis Signs and Symptoms Regardless of Previous Therapy in Two New Global Studies
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Study Confirms That Avastin Significantly Increases Chance of Living Without Disease Progression in Metastatic Breast Cancer
8. Long-Term Followup in Phase 3 CLL Trial Shows Genasense(R) is Associated with Significantly Increased Survival in All Responders
9. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
10. Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study
11. Study Demonstrates Lexapro(R) Significantly Improves Depression Symptoms in Adolescents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... WORTH, Fla. , Aug. 20, 2014  Glades Drugs, ... , is proud to announce its expansion into a ... , which will feature an 8,000-square-foot office space and state ... currently accepting applications for 100 open positions for the new ... at 4560 Lantana Road will serve as the chain,s corporate ...
(Date:8/20/2014)... Reportlinker.com announces that a new market research report ... Patient Scales Industry http://www.reportlinker.com/p01374301/Global-Patient-Scales-Industry.html ... markets for Patient Scales in US$ Thousand by ... Baby Scales, Chair Scales, and Under Bed Scales. ... US, Canada, Japan, Europe, Asia-Pacific, Latin America, and ...
(Date:8/20/2014)... England , August 20, 2014 ... be Conducted in the US  KalVista Pharmaceuticals ... macular edema (DME), today announces that it has begun ... novel plasma kallikrein inhibitor, KVD001, for the treatment of ... Sun of the Beetham Eye Institute, Joslin Diabetes Center; ...
Breaking Medicine Technology:Glades Drugs Moves to New Corporate Headquarters, 100 Open Positions 2Global Patient Scales Industry 2Global Patient Scales Industry 3Global Patient Scales Industry 4Global Patient Scales Industry 5Global Patient Scales Industry 6Global Patient Scales Industry 7Global Patient Scales Industry 8Global Patient Scales Industry 9Global Patient Scales Industry 10Global Patient Scales Industry 11Global Patient Scales Industry 12Global Patient Scales Industry 13Global Patient Scales Industry 14Global Patient Scales Industry 15Global Patient Scales Industry 16Global Patient Scales Industry 17Global Patient Scales Industry 18Global Patient Scales Industry 19KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 2KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 3KalVista Pharmaceuticals Announces Start of Clinical Development for Novel Treatment for Diabetic Macular Edema 4
... 2011 Insmed Incorporated (Nasdaq: INSM ), a ... call on Thursday, March 10th, 2011, at 8:30 AM EST, ... year-end 2010.  Insmed intends to issue its quarterly and year-end ... 10th. To participate in the live conference ...
... 23, 2011 Reportlinker.com announces that a new ... Global Fetal Monitors Industry ... report analyzes the worldwide markets for Fetal Monitors ... Antepartum Monitors, and Intrapartum Monitors. The report provides ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2010 Year-End Earnings Conference Call 2
(Date:8/21/2014)... AZ (PRWEB) August 21, 2014 Drake ... have donated $10,000 to support ovarian cancer research, according ... Cundiff, who is also the kicker for the Cleveland ... Cancer Event was matched by Colleen’s Dream Foundation and ... MD, an Assistant Professor in the Division of Gynecologic ...
(Date:8/21/2014)... 2014 InSilico Medicine, a ... addressing the challenges of a rapidly aging ... signalome-wide pathway analysis. This new method ... of gene expression data obtained using high-throughput ... the journal Frontiers in Molecular Biosciences, shows ...
(Date:8/21/2014)... Today, Fecbek.com, a leading wedding dresses manufacturer ... wedding dresses. And all these elegant, gorgeous and beautiful ... designers. , A wedding dress or wedding gown is ... ceremony. Color, style and ceremonial importance of the gown ... wedding participants. In order to satisfy every customer, Fecbek.com ...
(Date:8/20/2014)... Most people think of donating food around the ... for a variety of reasons—thus making these months some ... need, Dr. Bryne Willey of AlignLife of Springfield ... wanted to heighten awareness of the need in the ... in July food drive to collect non-perishable foods for ...
(Date:8/20/2014)... Skmen.com, the popular online supplier of men’s and women’s clothes, ... online. Along with this, the company has also launched ... fresh products are offered with great discounts and low shipping ... before August 31. , Skmen.com has more than 200 ... proportion of its clothes are selling well in the current ...
Breaking Medicine News(10 mins):Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 2Health News:Drake University’s Phi Gamma Delta (FIJI) and Colleen’s Dream Foundation Donate $10,000 to the University of Iowa’s Holden Cancer Center to Fight Ovarian Cancer 3Health News:OncoFinder, a new algorithm for minimizing errors in high-throughput transcriptome analysis 2Health News:Elegant Wedding Dresses Are for Sale at Fecbek.com 2Health News:AlignLife Springfield Office Donates 565 Canned Goods to Springfield Food Pantry 2Health News:Skmen.com: New Designs Of Mini Party Dresses Provided Online 2
... cancer will be the single leading cause of death ... stroke. Already cancer causes more deaths than HIV/AIDS, tuberculosis ... occur in developing countries, with more than a million ... Health Organization projections. , , Scot Remick, M.D., ...
... Speaker Nancy Pelosi spoke on the House floor this morning in ... Drug Administration (FDA) with authority to regulate tobacco products. The ... It passed the Senate yesterday and now goes to President ... remarks. , , "It,s really a ...
... 12 The following is a statement from Georges ... Health Association: , , "With today,s House passage of ... regulate tobacco products, our nation has finally turned the corner. ... to market their deadly products to our children and deceive ...
... HLS ) announced today that its board of ... share on its 6.5% Series A Convertible Perpetual Preferred Stock, ... July 1, 2009. , , About HealthSouth ... rehabilitative healthcare services. Operating in 26 states across the country ...
... association remains unclear, however, researchers say, , FRIDAY, June 12 ... the eye sometimes points outward are more likely to develop ... , About 1 percent of developmentally healthy U.S. children are ... line up and one looks away from the nose at ...
... N.Y., June 12 Misonix, Inc. (Nasdaq: ... device technology, which in Europe is used for the ... conditions, announced today that it has purchased three patents ... ProRhythm, Inc. The patents relate to HIFU transducer ...
Cached Medicine News:Health News:WVU Doctor Works to Reduce Cancer Burden in Africa 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 2Health News:Pelosi: Enabling the FDA to Regulate Tobacco a Giant Step Toward Making America Healthier 3Health News:Kids With Eye Condition at Risk for Poor Mental Health 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 2Health News:Misonix Announces the Purchase of Patents From ProRhythm, Inc. 3
... yet, the all-new Assure Pro Blood Glucose ... growing demands of the Long-Term Care profession. ... backlighting, and strip release offer better convenience, ... insert the test strip in the convenient ...
... For practices performing routine Holter,monitoring, ... QuickStep Wizard provides a,practical, no-nonsense ... managed health care,environment. This highly ... in a variety,of configurations at ...
... The Vision5L ... high-quality 5- or ... with a signal ... transfer using a ...
... II features a diagnostic interpretation,option ... Glasgow,(UG) algorithm. Unlike competitive products,which ... the UG,algorithm bases its analysis ... age, race, medication,and classification., Plus ...
Medicine Products: